STAT3 and colorectal carcinoma: In our effort to discover therapeutic vulnerability in CRC cells with PTEN loss, we previously conducted synthetic lethal drug screen for PTEN-deficient CRC and identified STAT3 inhibitor as one of the top candidate synthetic lethal drugs 12, 13.